Nebenwirkungen · Taxotere
TAXOTERE 20 mg/0.5 mL concentrate and solvent for solution for infusion · Abschnitt 4.8 · PDF-Seite 18
HOS-084581 · Präparat HOS-083047
Blood and lymphatic system Neutropenia (G3/4: 32%); disorders Febrile neutropenia (includes neutropenia associated with fever and antibiotic use) or neutropenic sepsis Metabolism and nutrition Anorexia disorders Psychiatric disorders Insomnia Nervous system disorders Paraesthesia; Headache; Dysgeusia; Hypoaesthesia Eye disorders Lacrimation increased; Conjunctivitis Cardiac disorders Cardiac failure Vascular disorders Lymphoedema Respiratory, thoracic and Epistaxis; Pharyngolaryngeal mediastinal disorders pain; Nasopharyngitis; Dyspnoea; Cough; Rhinorrhoea Gastrointestinal disorders Nausea; Diarrhoea; Vomiting; Constipation; Stomatitis; Dyspepsia; Abdominal pain Skin and subcutaneous tissue Alopecia; Erythema; Rash; Nail disorders disorders Musculoskeletal and connective Myalgia; Arthralgia; Pain in tissue disorders extremity; Bone pain; Back pain General disorders and Asthenia; Oedema peripheral; Lethargy administration site conditions Pyrexia; Fatigue; Mucosal inflammation; Pain; Influenza like illness; Chest pain; Chills Investigations Weight increased
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-22T16:45:00Z · SHA-256 518a48b73ebbaf067647805c9944cdf9fe7e9826b63e3719c8c44fa589fb5cce · Passage 750d9348d7df1c094c9afe5567c68d58c8ef8d90917d171b62d83ac1f64c16e0 · Zeichen 17448–19210 im Abschnitt